FDA Drug recall D-175-2013
buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavi…
- FDA Drug
- Class III
- terminated
- Published 2013-03-06
On 2013-03-06 the FDA classified a Class III recall of buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavi… by Actavis Pharmaceuticals, citing failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-175-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-01-04 |
| Published | 2013-03-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Actavis Pharmaceuticals |
| Distribution | US |
Product
buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217
Reason
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Identifiers
| code_info | Lot CB1D05A, |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-175-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.